Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. A Push by Patients. Along with patients, a Seattle-based palliative care physician by the name of Dr. Sunil Aggarwal was also named in the lawsuit.

Therapy 55

Therapy DEA Patients Clinical Trials 55

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. Quite frankly, the clinical trials couldn’t have come at a better time.

Clinical Trials 113

Clinical Trials Chronic Pain Hydroponic Strains 113

Veriheal

JUNE 29, 2022

The study was conducted by COMPASS Pathways , a mental healthcare company that is “dedicated to accelerating patient access to evidence-based innovation in mental health.” 233 patients with TRD from 10 countries in North America and Europe received either 1 milligram, 10 milligrams, or 25 milligrams of the COMP360 psilocybin.

Clinical Trials 103

Clinical Trials Blood Pressure Treatment Therapy 103

Canna Care Docs

OCTOBER 3, 2023

On top of overwhelming struggles or feelings, patients who have been diagnosed with a terminal illness can face a broad range of both physical and psychological effects. Some patients diagnosed with a terminal illness may begin to feel depressed or physically and mentally lethargic from the effects and symptoms of their disease.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

CannaMD

MAY 12, 2021

It’s well known that marijuana can be an agent for appetite stimulation, making it a valuable therapy for mitigating the weight loss sometimes associated with conditions such as HIV/AIDS and cancer. The condition can lead to weight gain and obesity. This leads to severe food restrictions and physical wasting.

Marijuana 119

Marijuana Therapy Conditions Food 119

Cannabis Law Report

FEBRUARY 24, 2022

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. 01.015 of the FDR before providing the new drug to a patient. Timeline of Medicinal Legalization in Canada. Pursuant to subsection C.08.010(1)

Therapy 52

Therapy Access Clinical Trials Treatment 52

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). Secondary endpoint of 50% responder rate at 30.4%, consistent with the Marigold Phase 3 CDKL5 deficiency disorder trial results. reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

MMJ Recs

NOVEMBER 30, 2023

While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients. Medical marijuana has shown potential in treating a wide range of medical conditions, including epilepsy. Some patients have shared their experiences with using MMJ to manage their condition.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

Veriheal

MAY 25, 2023

Ketamine Clinics Are an Evolutionary Addition to U.S. Healthcare Ketamine therapy has delivered positive results for patients when used in a structured outpatient setting. In Manhattan alone, 12 clinics have already opened their doors. 0.75mg/kg over 40 minutes) were administered to 100 patients over two weeks.

Medicine 98

Medicine Blood Pressure Therapy Clinical Trials 98

Cannabis Law Report

AUGUST 14, 2021

Cann Group CEO Peter Crock said of the products: “Satipharm CBD capsules were one of the first medicinal cannabis products available to approved patients in Australia (under the Special Access Scheme) and have been successfully used in a variety of medical conditions since 2017. Shares in Cann Group were up 3.33 per cent to $0.31

CBD 105

CBD Clinical Trials Programs Medicine 105

Cannabis Law Report

APRIL 21, 2022

The availability of larger quantities of cGMP-compliant MDMA will facilitate ongoing clinical trials and provide for future therapeutic use following anticipated regulatory approvals. Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public .

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

MAY 31, 2022

The first path, that of traditional medicine, currently offers patients limited options. The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

NewsMunchies

AUGUST 25, 2021

It is a way of life for those suffering with debilitating medical conditions that bring about widespread body aches, joint pain, and muscle tension. CBD, short for cannabidiol, claims to treat a variety of conditions including pain, anxiety, and insomnia, just to name a few. Chronic pain represents an emerging public health issue.

CBD 98

CBD Chronic Pain Clinical Trials Oil 98

The Blunt Truth

DECEMBER 23, 2020

These companies faced administrative actions by the FTC for “making a wide range of scientifically unsupported claims about their ability to treat serious health conditions,” such as cancer, Alzheimer’s disease, and pain relief. The warning letters address the illegal marketing of unapproved CBD products claiming to treat medical conditions.

CBD 103

CBD Food Safety Clinical Trials 103

Project CBD

NOVEMBER 11, 2023

And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. I have many patients that want to use cannabis, and they who ask me what product should they get? You can’t say that about most other medicines.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

Project CBD

FEBRUARY 28, 2023

Under section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act — in what some refer to as the “drug preclusion clause” 4 — any substance that is an active ingredient in an approved drug product, or that is being publicly investigated as such, is excluded from the definition of a legal dietary supplement ingredient. 2021;56:530-543.

CBD 144

CBD Seed-To-Sale Food Access 144

Veriheal

OCTOBER 13, 2020

Elevated levels of stress can even land these individuals in more discomfort, with IBD patients risking hospitalization due to inflammation. Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. What is IBS?

Digestion 123

Digestion Treatment Conditions Research and Development 123

The Cannigma

MARCH 7, 2022

CBN’s ability to target CB2 receptors, in comparison to THC (which prefers the CB1 receptor), gives it better credibility in treating autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. What can the current clinical trials tell us?

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

JULY 29, 2021

Food and Drug Administration for Generally Recognized as Safe (GRAS) is being pursued. GRAS status will allow for the broad application of this novel ingredient in foods as well as dietary supplements. PCT/CA2021/050886, with a filing date of June 28, 2021. Through the Tetra partnership with Thorne HealthTech, a submission to the U.S.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

United Patients Group

JANUARY 5, 2023

They can be found in certain foods and supplements, including yogurt, kefir and kombucha. Probiotics also occur naturally in fermented foods such as sauerkraut and pickles. They also reduce inflammation in the body and fight off viruses and harmful germs that may enter through food or water. What are Probiotics?

Digestion 88

Digestion Research and Development Food Strains 88

Cannabis Law Report

AUGUST 19, 2021

Britain’s Food Standards Agency now regulates the sector and its marketing, after the European Union classified CBD as food in 2019. Faced with booming sales, professor Sagnik Bhattacharyya, who researches psychotic and substance abuse disorders at King’s College London, says clinical trials are needed.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

Cannabis Law Report

OCTOBER 13, 2021

Filed in support of the Company’s CYB004 pre-clinical development program, the PCT filing serves to increase the Company’s library of drug delivery modalities directed to optimal delivery of psychedelics and further strengthens Cybin’s growing IP portfolio. Vigorous scientific research and clinical trials are needed.

Clinical Trials 52

Clinical Trials Research and Development Treatment Conditions 52

Veriheal

APRIL 11, 2022

You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

DECEMBER 11, 2021

“More than 40,000 patients have used cannabis to treat their respective illnesses. These clinics offer patients two types of medical cannabis: oil extracted from the seeds, and traditional cannabis remedies that use various parts of the plant including the leaves, roots or flowers. Most are cancer patients.

Oil 52

Oil Blood Pressure Concentrates Patients 52

Cannabis Law Report

JANUARY 3, 2022

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that the first patient has been dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

Cannabis Law Report

SEPTEMBER 1, 2021

The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. After Approval, It’s Off to Treatment Clinics. Goldsmith is Compass Pathways’ chairman, CEO, and co-founder. Diversified Drug Development.

Research and Development 102

Research and Development Therapy Clinical Trials Pharmaceutical 102

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Veriheal

JUNE 7, 2021

It turns out that this blissful drug, MDMA, has the potential to be used effectively as a treatment for certain conditions- some of which are in urgent need of effective medical assistance. . MDMA has also reportedly been used with over 1,000 individuals in clinical trials , with no adverse effects to report. . What is MDMA?

Therapy 82

Therapy Treatment Conditions Clinical Trials 82

SpeedWeed

SEPTEMBER 4, 2021

“DEA is proposing significant increases to the APQs of the schedule I substances psilocybin, psilocin, marihuana, and marihuana extract, which are directly related to increased interest by DEA registrants in the use of hallucinogenic controlled substances for research and clinical trial purposes,” the DEA writes. .

DEA 52

DEA Research and Development Clinical Trials Extraction 52

Cannabis Law Report

JANUARY 19, 2022

GMP psilocybin previously manufactured by Psygen personnel in collaboration with a licensed dealer using Psygen’s methods has already been used in clinical trials for development of therapeutic products. “A primary application for psychedelics is to support psychotherapy for treatment of mental health conditions. .

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Conditions 52

Cannabis Law Report

JULY 9, 2021

Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

DECEMBER 14, 2019

In October, some Canadian firms adjusted their global expansion plans in Australia due to the conditions seen in the cannabis industry. The uptick has been represented in the patient count, as well. There’s also been a decrease in pricing pressure for medical cannabis patients throughout the country.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Cannabis Law Report

NOVEMBER 25, 2021

The Food and Drug Administration (FDA) recently approved the use of CBD to help treat the condition in individuals as young as two years old. The use of CBD seems to ease the number of seizures patients have considerably, which has caused many medical professionals to take notice and begin prescribing it to others.

CBD 52

CBD Clinical Trials Epilepsy Chronic Pain 52

Cannabis Law Report

SEPTEMBER 22, 2021

Food and Drug Administration. These drugs have an excellent safety profile with experience in over 1,500 patients in clinical studies to date. Namodenoson has been granted Orphan Drug Designation in the U.S. and Europe and Fast Track Designation as a second line treatment for HCC by the U.S.

Clinical Trials 52

Clinical Trials Treatment Business Events 52

Greencamp

FEBRUARY 17, 2019

Usually, the diagnosis involves excluding conditions like parasitic infections, lactose intolerance tests and small intestinal bacterial overgrowth which all produce symptoms like IBS. Constant gut symptoms often lead to the development of other conditions like anxiety , depression , migraines , sleeping problems and fatigue.

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). Food and Drug Administration (FDA) to cities and counties. What are the exact legalities behind ketamine?

Therapy 91

Therapy Legalization Chronic Pain DEA 91

Cannabis Law Report

NOVEMBER 9, 2021

As an institution dedicated to diagnosing and treating serious blood diseases and with the ability to pursue investigational medicines from development to manufacture and clinical trial for patients who have exhausted all approved treatment options, having a cost-effective and rapid production chain is integral to ÚHKT’s mission.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52